Correspondence from Medicines & Healthcare products Regulatory Agency (MHRA), re: Geroprotector research and patient benefit of scientific innovation, 23 March 2026
| Published: | Wednesday 1 July 2026 @ 14:00 |
|---|---|
| Publication type: | Correspondence |
| Committee: | Science, Innovation and Technology Committee |